Published in World J Gastroenterol on January 14, 2008
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C. J Gastroenterol (2016) 1.07
Hepatic disorders in chronic kidney disease. Nat Rev Nephrol (2010) 1.01
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa. Int J Nanomedicine (2014) 0.89
Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol (2012) 0.80
Hepatitis C and kidney transplantation. Int J Nephrol (2011) 0.77
The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon (2016) 0.77
Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C. Clin Exp Nephrol (2012) 0.76
Health care-associated hepatitis C virus infection. World J Gastroenterol (2014) 0.76
Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment. J Clin Transl Hepatol (2016) 0.75
Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study. Indian J Nephrol (2016) 0.75
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE). J Hepatol (2006) 3.31
Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther (2003) 1.82
Hepatitis C infection and the patient with end-stage renal disease. Hepatology (2002) 1.53
Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol (2006) 1.53
Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. Nephrol Dial Transplant (2001) 1.50
Laparoscopic evaluation of liver disease in chronic renal failure prior to renal transplantation. Gastrointest Endosc (1997) 1.42
Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int (1997) 1.21
Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev (2003) 1.13
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepat (2006) 1.06
Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant (2005) 1.01
Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol (2000) 0.99
Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol (1998) 0.92
Hepatitis C markers in hemodialysis patients. J Clin Microbiol (1993) 0.92
National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial (2002) 0.91
Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig Dis Sci (2006) 0.88
High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy. J Infect Dis (1997) 0.87
Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis. World J Gastroenterol (2006) 0.86
Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Am J Nephrol (2002) 0.85
Prevention and treatment of hepatitis C virus recurrence after liver transplantation. J Hepatol (2004) 0.82
Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther (2004) 0.81
Prevalence of hepatitis C antibodies among hemodialysis patients in Al-hasa region of saudi arabia. Saudi J Kidney Dis Transpl (2008) 0.81
Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients. Transplant Proc (2000) 0.79
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection? Clin Transplant (2005) 0.79
Transmission of hepatitis C by blood splash into conjunctiva in a nurse. Am J Infect Control (2003) 1.76
Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. Yonsei Med J (2003) 1.25
A national survey of surgical antibiotic prophylaxis in Turkey. Infect Control Hosp Epidemiol (2003) 1.16
Acute hepatitis: a rare complication of Epstein-Barr virus (EBV) infection. J Infect Dev Ctries (2010) 1.02
Risk factors for enteric perforation in patients with typhoid Fever. Am J Epidemiol (2004) 1.02
Sacroiliitis caused by Salmonella typhi. J Infect Dev Ctries (2009) 1.01
A simple validated prediction rule to diagnose typhoid fever in Turkey. Trans R Soc Trop Med Hyg (2006) 0.99
Cervical intramedullary granuloma of Brucella: a case report and review of the literature. Eur Spine J (2006) 0.96
Clinical and laboratory features of brucellosis in two university hospitals in Southeast Turkey. Trop Doct (2006) 0.91
Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother (2011) 0.91
Brucellar epididymo-orchitis in southeastern part of Turkey: an 8 year experience. Braz J Infect Dis (2010) 0.87
Impact of a multidimensional infection control approach on central line-associated bloodstream infections rates in adult intensive care units of 8 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Ann Clin Microbiol Antimicrob (2013) 0.86
Snakebite-induced acute kidney injury: data from Southeast Anatolia. Ren Fail (2008) 0.86
Pyogenic liver abscess caused by community-acquired multidrug resistance Pseudomonas aeruginosa. Braz J Infect Dis (2010) 0.82
Prospective surveillance study for risk factors of central venous catheter-related bloodstream infections. Am J Infect Control (2004) 0.81
Comparison of lamivudine and alpha-interferon combination with alpha-interferon alone in the treatment of HBeAg-positive chronic hepatitis B. Indian J Gastroenterol (2006) 0.81
A case of brucellar spondylodiscitis involving the cervical spine. J Back Musculoskelet Rehabil (2009) 0.79
A case of meningitis caused by Streptococcus pyogenes in a previously healthy woman. J Infect Dev Ctries (2009) 0.79
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B. J Infect Dev Ctries (2014) 0.79
The evaluation of bacteriology in perianal abscesses of 81 adult patients. Braz J Infect Dis (2010) 0.79
The effect of a restriction policy on the antimicrobial consumption in Turkey: a country-wide study. Eur J Clin Pharmacol (2005) 0.78
Impact of a multidimensional infection control approach on catheter-associated urinary tract infection rates in adult intensive care units in 10 cities of Turkey: International Nosocomial Infection Control Consortium findings (INICC). Am J Infect Control (2013) 0.78
The accuracy and validity of a weekly point-prevalence survey for evaluating the trend of hospital-acquired infections in a university hospital in Turkey. Int J Infect Dis (2011) 0.78
Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone. J Ocul Pharmacol Ther (2011) 0.77
Therapeutic effect of spiramycin in brucellosis. Pediatr Int (2003) 0.76
An unusual presentation of brucellosis: acute hepatitis. Braz J Infect Dis (2011) 0.75
Pregnancy and H1N1 infection in Southeast Turkey. J Infect Dev Ctries (2012) 0.75
Evaluation of false negativity of the Widal test among culture proven typhoid fever cases. J Infect Dev Ctries (2008) 0.75
Four-year study of entecavir efficacy and safety in nucleos(t)ide-naïve HBeAg positive chronic hepatitis B patients. Acta Clin Croat (2014) 0.75
Are sinus-track cultures reliable for identifying the causative agent in chronic osteomyelitis? Arch Orthop Trauma Surg (2009) 0.75
Critical evaluation of antimicrobial use--a Turkish university hospital example. J Infect Dev Ctries (2013) 0.75
The efficacy of dexamethasone treatment in massive enteric bleeding in typhoid fever. Trop Doct (2009) 0.75
The efficacy of dexamethasone treatment in adult patients with acute bacterial meningitis. Neurosciences (Riyadh) (2008) 0.75
A case report and literature review: osteomyelitis caused by community-associated methicillin resistant Staphylococcus aureus. J Infect Dev Ctries (2011) 0.75